- Home
- KIND vs SANA Comparison
KIND vs SANA Comparison
Compare KIND & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIND
- SANA
- Stock Information
- Founded
- KIND 2011
- SANA 2018
- Country
- KIND United States
- SANA United States
- Employees
- KIND N/A
- SANA N/A
- Industry
- KIND Computer Software: Programming Data Processing
- SANA Medicinal Chemicals and Botanical Products
- Sector
- KIND Technology
- SANA Health Care
- Exchange
- KIND Nasdaq
- SANA Nasdaq
- Market Cap
- KIND 608.3M
- SANA 489.5M
- IPO Year
- KIND N/A
- SANA 2021
- Fundamental
- Price
- KIND $1.62
- SANA $3.18
- Analyst Decision
- KIND Buy
- SANA Strong Buy
- Analyst Count
- KIND 4
- SANA 6
- Target Price
- KIND $2.56
- SANA $10.00
- AVG Volume (30 Days)
- KIND 2.1M
- SANA 5.5M
- Earning Date
- KIND 08-06-2025
- SANA 08-07-2025
- Dividend Yield
- KIND N/A
- SANA N/A
- EPS Growth
- KIND N/A
- SANA N/A
- EPS
- KIND N/A
- SANA N/A
- Revenue
- KIND $248,306,000.00
- SANA N/A
- Revenue This Year
- KIND $1.77
- SANA N/A
- Revenue Next Year
- KIND $10.72
- SANA N/A
- P/E Ratio
- KIND N/A
- SANA N/A
- Revenue Growth
- KIND 12.01
- SANA N/A
- 52 Week Low
- KIND $1.32
- SANA $1.26
- 52 Week High
- KIND $3.00
- SANA $7.40
- Technical
- Relative Strength Index (RSI)
- KIND 55.06
- SANA 62.39
- Support Level
- KIND $1.55
- SANA $2.60
- Resistance Level
- KIND $1.66
- SANA $3.01
- Average True Range (ATR)
- KIND 0.07
- SANA 0.27
- MACD
- KIND 0.00
- SANA -0.01
- Stochastic Oscillator
- KIND 68.75
- SANA 65.24
About KIND Nextdoor Holdings Inc.
Nextdoor Holdings Inc is the platform to connect to the neighborhoods. The purpose is to cultivate a kinder world where everyone has a neighborhood. Neighbors around the world turn to Nextdoor daily to receive trusted information, give and get help, get things done, and build real-world connections with nearby neighbors, businesses, and public services. It offers a comprehensive suite of advertising solutions designed to deliver exceptional value for businesses of all size.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.